Mechanisms and Outcome-Prognostication for Paresthesia-based and -Free Spinal Cord Stimulation

Recruiting N/A Interventional Study
Neuropathic Pain Chronic Pain
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
90 (estimated)
Sponsor
University Health Network, Toronto · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Spinal cord stimulation (SCS) relies on stimulation of pain-relieving pathways in the spinal cord to treat chronic neuropathic pain. Traditional paresthesia-based SCS (PB-SCS) relies on providing analgesia through stimulation of spinal cord dorsal columns but it is often associated with attenuation of analgesic benefit and lack of acceptance of paresthesias. Recently introduced three different par…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Adults, 18 - 80 years of age, with refractory neuropathic pain (as per clinical features and DN4 score \> 3/10) in back and or lower limbs for more than 3 months following lumbar spine surgery 2. Severity of pain \> 3/10 on NRS and ODI score for disability \>40/100; and 3. Pa…
Contacts

Anuj Bhatia, MD FRCPC

(416) 603-5800

anuj.bhatia@uhn.ca

CONTACT

Jamal Kara

(416) 603-5800

jamal.kara@uhn.ca

CONTACT